Profile
Christopher Silber worked as a Principal at Hospira, Inc. He then served as the Vice President-Clinical Affairs at OVATION Pharmaceuticals, Inc. from 2008 to 2010.
Later, he held the position of Senior Vice President-Clinical Development at SAGE Therapeutics, Inc. from 2017 to 2020.
Dr. Silber also worked as the Chief Medical Officer at Nocion Therapeutics, Inc. Currently, he is the Chief Medical Officer at Vigil Neuroscience, Inc. Dr. Silber completed his undergraduate studies at Tufts University and obtained a doctorate degree from Jacobs School of Medicine & Biomedical Sciences.
Former positions of Christopher Silber
| Companies | Position | End |
|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Chief Tech/Sci/R&D Officer | 2024-03-19 |
| SAGE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Chief Tech/Sci/R&D Officer | 2010-03-28 |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Chief Tech/Sci/R&D Officer | - |
| HOSPIRA, INC. | Corporate Officer/Principal | - |
Training of Christopher Silber
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Hospira, Inc.
Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals | Health Technology |
SAGE Therapeutics, Inc.
SAGE Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel medicines for central nervous system disorders | Health Technology |
Jacobs School of Medicine & Biomedical Sciences
Jacobs School of Medicine & Biomedical Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nocion Therapeutics, Inc.
Nocion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops small molecules for nociceptors | Health Technology |
Vigil Neuroscience, Inc.
Vigil Neuroscience, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics for neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Christopher Silber
















